While an ACh deficit is just one of the many factors (for example, the deposition of the amyloid-β (Aβ) peptide in the brain) contributing to AD, the current market-approved drugs for alleviating AD symptoms are AChE inhibitors, including donepezil, tacrine, and galanthamine [3,4]. The gene discussed is ACHE; the disease is Alzheimer disease.